Yacine Barèche

2.3k total citations
24 papers, 1.0k citations indexed

About

Yacine Barèche is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Yacine Barèche has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Yacine Barèche's work include Cancer Immunotherapy and Biomarkers (10 papers), Adenosine and Purinergic Signaling (5 papers) and Cancer Genomics and Diagnostics (5 papers). Yacine Barèche is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Adenosine and Purinergic Signaling (5 papers) and Cancer Genomics and Diagnostics (5 papers). Yacine Barèche collaborates with scholars based in Belgium, Canada and United States. Yacine Barèche's co-authors include Christos Sotiriou, Françoise Rothé, Martine Piccart, David Venet, Michail Ignatiadis, John Stagg, Philippe Aftimos, Laurence Buisseret, Sandra Pommey and Marianne Paesmans and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Scientific Reports.

In The Last Decade

Yacine Barèche

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yacine Barèche Belgium 14 600 356 321 249 200 24 1.0k
Jörn Dietrich Germany 20 465 0.8× 242 0.7× 706 2.2× 308 1.2× 17 0.1× 33 1.1k
Ecaterina E. Dumbrava United States 17 647 1.1× 194 0.5× 379 1.2× 185 0.7× 14 0.1× 115 1.0k
Liangrong Shi China 17 663 1.1× 180 0.5× 255 0.8× 544 2.2× 16 0.1× 33 1.2k
Smruthi Vijayaraghavan United States 10 571 1.0× 126 0.4× 412 1.3× 110 0.4× 19 0.1× 15 914
Stéphanie Lheureux Canada 15 735 1.2× 135 0.4× 331 1.0× 161 0.6× 13 0.1× 46 991
Rong En Tay United States 5 890 1.5× 173 0.5× 571 1.8× 894 3.6× 14 0.1× 8 1.5k
Qingyang Lei China 8 441 0.7× 225 0.6× 333 1.0× 392 1.6× 10 0.1× 15 852
Xuhui Bao United States 14 357 0.6× 240 0.7× 475 1.5× 396 1.6× 9 0.0× 32 1.1k
Casey R. Ager United States 12 507 0.8× 247 0.7× 399 1.2× 685 2.8× 12 0.1× 27 1.1k
Yuchen Bai United States 14 452 0.8× 226 0.6× 693 2.2× 53 0.2× 30 0.1× 21 1.0k

Countries citing papers authored by Yacine Barèche

Since Specialization
Citations

This map shows the geographic impact of Yacine Barèche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yacine Barèche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yacine Barèche more than expected).

Fields of papers citing papers by Yacine Barèche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yacine Barèche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yacine Barèche. The network helps show where Yacine Barèche may publish in the future.

Co-authorship network of co-authors of Yacine Barèche

This figure shows the co-authorship network connecting the top 25 collaborators of Yacine Barèche. A scholar is included among the top collaborators of Yacine Barèche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yacine Barèche. Yacine Barèche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buisseret, Laurence, Yacine Barèche, David Venet, et al.. (2024). The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab. ESMO Open. 9(5). 102964–102964. 4 indexed citations
2.
Allard, Bertrand, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.. (2023). Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma. Cell Reports Medicine. 4(9). 101188–101188. 19 indexed citations
3.
Jacoberger-Foissac, Célia, Isabelle Cousineau, Yacine Barèche, et al.. (2022). CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer. Cancer Immunology Research. 11(1). 56–71. 46 indexed citations
4.
Cheng, Zhao, Paméla Thébault, Yacine Barèche, et al.. (2022). Abstract 1361: Crosstalk between peripherally expanded T cells and Tfh-like cells in shaping effector functions of CD8 T cells in ovarian cancer. Cancer Research. 82(12_Supplement). 1361–1361.
5.
Barèche, Yacine, Deirdre Kelly, Farnoosh Abbas‐Aghababazadeh, et al.. (2022). Leveraging big data of immune checkpoint blockade response identifies novel potential targets. Annals of Oncology. 33(12). 1304–1317. 30 indexed citations
6.
Barèche, Yacine, Deirdre Kelly, Farnoosh Abbas‐Aghababazadeh, et al.. (2021). Leveraging Big Data of Immune Checkpoint Blockade Response Identifies Novel Potential Targets. SSRN Electronic Journal. 2 indexed citations
7.
Barèche, Yacine, Sandra Pommey, Laurence Buisseret, et al.. (2021). High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer. Journal for ImmunoTherapy of Cancer. 9(3). e001965–e001965. 21 indexed citations
8.
Rothé, Françoise, Matteo Lambertini, Oranite Goldrat, et al.. (2021). Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients. Frontiers in Oncology. 11. 5 indexed citations
9.
Rothé, Françoise, Marion Maetens, Ghizlane Rouas, et al.. (2019). CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial. BMC Cancer. 19(1). 304–304. 14 indexed citations
10.
Stamatopoulos, Basile, et al.. (2019). MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries. Scientific Reports. 9(1). 9636–9636. 29 indexed citations
11.
Desmedt, Christine, Isabelle Veys, Bastien Nguyen, et al.. (2019). Abstract P3-07-04: Molecular characterization of mucinous breast cancers. Cancer Research. 79(4_Supplement). P3–7. 1 indexed citations
12.
Nguyen, Bastien, Isabelle Veys, Sophia Leduc, et al.. (2019). Genomic, Transcriptomic, Epigenetic, and Immune Profiling of Mucinous Breast Cancer. JNCI Journal of the National Cancer Institute. 111(7). 742–746. 20 indexed citations
13.
Barèche, Yacine, David Venet, Michail Ignatiadis, et al.. (2018). Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis. Annals of Oncology. 29(4). 895–902. 254 indexed citations
14.
Ignatiadis, Michail, Gert Van den Eynden, Marco Fornili, et al.. (2018). Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy. JNCI Journal of the National Cancer Institute. 111(1). 69–77. 58 indexed citations
15.
Ignatiadis, M., Roberto Salgado, Marco Fornili, et al.. (2018). Tumor infiltrating lymphocytes in patients receiving trastuzumab/pertuzumab-based chemotherapy: A TRYPHAENA substudy. European Journal of Cancer. 92. S15–S15. 8 indexed citations
16.
Brouwers, Barbara, Debora Fumagalli, Sylvain Brohée, et al.. (2017). The footprint of the ageing stroma in older patients with breast cancer. Breast Cancer Research. 19(1). 78–78. 21 indexed citations
17.
Turcotte, Martin, David Allard, Deepak Mittal, et al.. (2017). CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy. Cancer Research. 77(20). 5652–5663. 94 indexed citations
18.
Buisseret, Laurence, Sandra Pommey, Bertrand Allard, et al.. (2017). Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial. Annals of Oncology. 29(4). 1056–1062. 147 indexed citations
19.
Božović‐Spasojević, Ivana, Dimitrios Zardavas, Sylvain Brohée, et al.. (2016). The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data. Clinical Cancer Research. 23(11). 2702–2712. 84 indexed citations
20.
Barèche, Yacine, Laure Lapasset, Carine Chavey, et al.. (2016). Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice. International Journal of Obesity. 41(3). 390–401. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörn Dietrich Breakdown of academic impact, for papers by Ecaterina E. Dumbrava Breakdown of academic impact, for papers by Liangrong Shi Breakdown of academic impact, for papers by Smruthi Vijayaraghavan Breakdown of academic impact, for papers by Stéphanie Lheureux Breakdown of academic impact, for papers by Rong En Tay Breakdown of academic impact, for papers by Qingyang Lei Breakdown of academic impact, for papers by Xuhui Bao Breakdown of academic impact, for papers by Casey R. Ager Breakdown of academic impact, for papers by Yuchen Bai
Rankless by CCL
2026